Drug Shortage Report for APO-MEDROXY TABLETS

Last updated on 2024-03-22 History
Report ID 189665
Drug Identification Number 02244727
Brand name APO-MEDROXY TABLETS
Common or Proper name MEDROXYPROGESTERONE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) MEDROXYPROGESTERONE ACETATE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code G03DA
ATC description PROGESTOGENS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2023-04-24
Estimated end date 2023-08-18
Actual end date 2023-08-17
Shortage status Resolved
Updated date 2024-03-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2024-03-22 English Compare
v23 2023-08-18 French Compare
v22 2023-08-18 English Compare
v21 2023-08-12 French Compare
v20 2023-08-12 English Compare
v19 2023-07-28 English Compare
v18 2023-06-23 French Compare
v17 2023-06-23 English Compare
v16 2023-06-02 French Compare
v15 2023-06-02 English Compare
v14 2023-05-26 French Compare
v13 2023-05-26 English Compare
v12 2023-05-06 French Compare
v11 2023-05-06 English Compare
v10 2023-05-06 French Compare
v9 2023-05-06 English Compare
v8 2023-05-06 French Compare
v7 2023-05-06 English Compare
v6 2023-05-06 French Compare
v5 2023-05-06 English Compare

Showing 1 to 20 of 24